BeStock  
Stocks › Biotechnology › DMRA

Damora Therapeutics DMRA

US equityMarket cap rank #2901Biotechnology
$23.22 −$1.08 (-4.44%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $23.22 0.00%
Open$23.81
Prev close$24.30
Day range$23.13 – $24.51
Volume643.4K
Market cap$1.44B
P/E (TTM)13.6
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$46.67+101.0% vs. price
  • Buy 100%
Low $40.00Now $23.22Avg $46.67High $59.00

Recent rating changes

The last 20 actions on file set price targets from $40.00 to $60.00, averaging $45.53.

DateFirmRatingTarget
5 Nov 2026 Wedbush BUY $40.00
5 Nov 2026 Guggenheim BUY $59.00
5 Nov 2026 Leerink Partners BUY $51.00
5 Nov 2026 H.C. Wainwright BUY $45.00
4 Nov 2026 RBC Capital BUY $40.00
29 Sep 2026 Wedbush BUY $40.00
24 Sep 2026 Guggenheim BUY $60.00
18 Sep 2026 LifeSci Capital BUY $45.00
11 Aug 2026 LifeSci Capital BUY $45.00
11 Aug 2026 Wedbush BUY $40.00
11 Aug 2026 Jefferies BUY $50.00
11 Aug 2026 H.C. Wainwright BUY $45.00
10 Aug 2026 TD Cowen BUY –
10 Aug 2026 RBC Capital BUY $40.00
6 Aug 2026 LifeSci Capital BUY $45.00
6 Aug 2026 Wedbush BUY $40.00
5 Aug 2026 H.C. Wainwright BUY $45.00
30 Jul 2026 Wedbush BUY $40.00
26 Jul 2026 Jefferies BUY $50.00
21 Jul 2026 H.C. Wainwright BUY $45.00

Discussion

No comments yet — be the first to weigh in on DMRA.

Sign in to join the discussion.

Scroll to Top